학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 86건 | 목록 1~20
Academic Journal
Seguí E; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Brasó-Maristany F; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Pascual T; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Sanfeliu E; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Pathology Department, Hospital Clinic of Barcelona, Barcelona, Spain.; Victoria I; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Saura C; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Hierro C; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; López-González A; Complejo Asistencial Universitario de León, León, Spain.; Izarzugaza Y; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Ciruelos E; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Gavilá J; SOLTI Cancer Research Group, Barcelona, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain.; Racca F; IOB-Hospital Quironsalud Barcelona, Barcelona, Spain.; Cejalvo JM; SOLTI Cancer Research Group, Barcelona, Spain; Hospital Clínico Universitario de Valencia, INCLIVA (Instituto de Investigación Sanitaria), Universidad Valencia, Valencia, Spain.; Amillano K; Hospital Universitari Sant Joan de Reus, Reus, Spain.; Paz-Ares L; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Instituto de Salud Carlos III, Madrid, Spain.; Juan M; Immunology Department, Immunotherapy Platforms, Hospital Clinic de Barcelona, Barcelona, Spain.; Felip E; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; González B; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Arance A; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Martín-Liberal J; Catalan Institute of Oncology (ICO), Hospitalet, Barcelona, Spain.; Conte B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Walbaum B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Indacochea A; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Castillo O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Blasco P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pardo F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Aguirre Á; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Sirenko V; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; González X; SOLTI Cancer Research Group, Barcelona, Spain; Catalan Institute of Oncology (ICO), Hospitalet, Barcelona, Spain; Institut Oncològic Dr. Rosell, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ferrero-Cafiero JM; SOLTI Cancer Research Group, Barcelona, Spain.; Mulero-Sánchez A; SOLTI Cancer Research Group, Barcelona, Spain.; Salvador F; SOLTI Cancer Research Group, Barcelona, Spain.; Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Mesía R; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; Cervantes A; Hospital Clínico Universitario de Valencia, INCLIVA (Instituto de Investigación Sanitaria), Universidad Valencia, Valencia, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Instituto de Salud Carlos III, Madrid, Spain.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; IOB-Hospital Quironsalud Barcelona, Barcelona, Spain. Electronic address: alprat@clinic.cat.; Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; IOB-Hospital Quironsalud Barcelona, Barcelona, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Instituto de Salud Carlos III, Madrid, Spain; Medicine Department, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Spain.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Pascual T; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oliveira M; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escrivá-de-Romaní S; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Pernas S; SOLTI Cancer Research Group, Barcelona, Spain; Institut Catala d'Oncologia-IDIBELL, L'Hospitalet, Barcelona, Spain.; Paré L; SOLTI Cancer Research Group, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Adamo B; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Martínez E; Department of Medical Oncology, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Castellón, Spain.; Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Perelló A; Department of Medical Oncology, Hospital Son Espases, Palma, Spain.; Galan M; Department of Medical Oncology, Hospital Son Llàtzer, Palma, Spain.; Melé M; Department of Medical Oncology, Hospital Sant Joan, Reus, Spain.; Villanueva L; SOLTI Cancer Research Group, Barcelona, Spain.; Gonzalez-Rodriguez M; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Tolosa P; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; González-Farré B; Department of Pathology, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Canes J; SOLTI Cancer Research Group, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ferrero-Cafiero JM; SOLTI Cancer Research Group, Barcelona, Spain.; González-Farré X; SOLTI Cancer Research Group, Barcelona, Spain; Institut Oncològic Dr. Rosell, Barcelona, Spain; Hospital General de Catalunya, Sant Cugat del Vallès, Barcelona, Spain; Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.; Villagrasa P; SOLTI Cancer Research Group, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Prat A; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat.; Ciruelos E; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Medical Oncology Department, HM Hospitales, Madrid, Spain. Electronic address: eva.ciruelos@gmail.com.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Conference
Laboratory Investigation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.; Tung N; Medical Oncology, Beth Israel Deaconess Medical Center, Boston.; Wolff AC; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore.; DeMichele A; Department of Medicine, University of Pennsylvania, Philadelphia, USA.; Cejalvo JM; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia; Breast Cancer Biology Research Group, Biomedical Research Institute INCLIVA, Valencia.; Martínez-Sáez O; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medicine, University of Barcelona, Barcelona; SOLTI Cancer Research Group, Barcelona.; Pascual T; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medicine, University of Barcelona, Barcelona; SOLTI Cancer Research Group, Barcelona.; Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.; Martín M; Department of Medical Oncology, Hospital Gregorio Marañón, Madrid; CIBERONC, Centro de Investigación Biomédica en Red de Cáncer, Madrid; GEICAM, Grupo Español de Investigación en Cáncer de Mama, Madrid.; Ciruelos E; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid; Medical Oncology Department, HM Hospitales, Madrid, Spain.; Harbeck N; Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center (CCC) Munich, LMU University Hospital, Munich, Germany.; Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain.; Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Prat A; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medicine, University of Barcelona, Barcelona; Reveal Genomics, Barcelona; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain. Electronic address: alprat@clinic.cat.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Conference
Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Villacampa G; SOLTI Breast Cancer Research Group, Barcelona; Statistics Unit, Vall d'Hebron Institute of Oncology, Barcelona.; Pascual T; SOLTI Breast Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Medical Oncology Department, Hospital Clínic, Barcelona.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona.; Paré L; Reveal Genomics, Barcelona.; Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Medical Oncology Department, Hospital Clínic, Barcelona.; Cortés J; International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona.; Ciruelos E; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid.; Martin M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, Madrid, Spain.; Conte P; San Camillo Hospital, IRCCS, Venezia Lido, Italy.; Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Fernandez A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Harbeck N; Breast Center, Ludwig Maximilians University-Grosshadern, Munich, Germany.; Marín-Aguilera M; Reveal Genomics, Barcelona.; Vivancos A; Cancer Genomics Group, VHIO, Barcelona, Spain.; Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Villagrasa P; Reveal Genomics, Barcelona.; Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Medical Oncology Department, Hospital Clínic, Barcelona; Reveal Genomics, Barcelona.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA. Electronic address: Sara_Tolaney@DFCI.HARVARD.EDU.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Ciruelos E; Department of Medical Oncology, Breast Cancer Unit, University Hospital 12 de Octubre, Avda. De Córdoba, s/n, 28041, Madrid, Spain. eva.ciruelos@gmail.com.; Jerusalem G; Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium.; Martin M; Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, GEICAM, CIBERONC, Madrid, Spain.; Tjan-Heijnen VCG; Department of Medical Oncology, GROW, Maastricht University Medical Centre, Maastricht, The Netherlands.; Neven P; Department of Oncology, Multidisciplinary Breast Center, KULeuven-University of Leuven, Leuven, Belgium.; Gavila J; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain.; Montemurro F; Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Generali D; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.; Lang I; Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary.; Martínez-Serrano MJ; Medical Department, Novartis Oncology, Barcelona, Spain.; Perelló MF; Medical Department, Novartis Oncology, Barcelona, Spain.; Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Medical Oncology, Istituto Oncologico Veneto, Padova, Italy.
Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Ciruelos, E
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어